Financial results - DUOMEDICA SRL

Financial Summary - Duomedica Srl
Unique identification code: 24345309
Registration number: J29/2310/2008
Nace: 8622
Sales - Ron
123.076
Net Profit - Ron
46.128
Employee
5
The most important financial indicators for the company Duomedica Srl - Unique Identification Number 24345309: sales in 2023 was 123.076 euro, registering a net profit of 46.128 euro and having an average number of 5 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Duomedica Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 31.159 44.436 48.492 63.592 64.360 61.701 115.073 125.530 145.369 123.076
Total Income - EUR 31.159 44.436 48.492 63.592 64.360 66.099 115.440 125.533 145.369 123.279
Total Expenses - EUR 20.191 21.894 34.860 36.007 34.507 63.936 55.187 48.224 65.631 75.919
Gross Profit/Loss - EUR 10.968 22.542 13.632 27.584 29.853 2.163 60.253 77.309 79.738 47.361
Net Profit/Loss - EUR 10.033 21.209 13.147 26.948 29.209 1.504 59.330 76.068 78.284 46.128
Employees 2 3 3 4 4 3 4 4 5 5
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -15.1%, from 145.369 euro in the year 2022, to 123.076 euro in 2023. The Net Profit decreased by -31.919 euro, from 78.284 euro in 2022, to 46.128 in the last year.

Check the financial reports for the company - Duomedica Srl

Rating financiar

Financial Rating -
Duomedica Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Duomedica Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Duomedica Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Duomedica Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Duomedica Srl - CUI 24345309

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 5.196 3.508 2.700 1.672 453 45.935 75.803 61.533 49.023 36.219
Current Assets 27.551 52.967 62.991 57.028 87.608 54.068 69.476 157.026 66.998 50.500
Inventories 3.257 4.049 4.170 3.088 3.671 3.158 0 0 0 0
Receivables 9.095 9.271 283 439 91 6.293 5.667 11.736 58.255 15.959
Cash 15.200 39.647 58.539 53.500 83.846 44.617 63.808 145.290 8.744 34.541
Shareholders Funds 32.056 53.532 30.505 56.937 85.102 86.251 143.946 216.821 100.706 81.589
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 691 2.943 35.186 1.762 2.959 13.752 1.333 1.860 15.681 5.131
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 50.500 euro in 2023 which includes Inventories of 0 euro, Receivables of 15.959 euro and cash availability of 34.541 euro.
The company's Equity was valued at 81.589 euro, while total Liabilities amounted to 5.131 euro. Equity decreased by -18.812 euro, from 100.706 euro in 2022, to 81.589 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Duomedica Srl

Comments - Duomedica Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.